Adoption of new drugs by physicians: a survival analysis
<p>Abstract</p> <p>Background</p> <p>New drugs often substitute others cheaper and with a risk-benefit balance better established. Our aim was to analyse the diffusion of new drugs during the first months of use, examining the differences between family physicians and s...
Main Authors: | Garjón Francisco, Azparren Ana, Vergara Iván, Azaola Borja, Loayssa Jose |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6963/12/56 |
Similar Items
-
Prescription pattern of antihypertensive drugs: An experience from a secondary care hospital in the United Arab Emirates
by: Maryam Salem Alkaabi, et al.
Published: (2019-01-01) -
Professional practices and perception towards rational use of medicines according to WHO methodology in United Arab Emirates
by: Abdul Rasool BK, et al.
Published: (2010-03-01) -
Multimodal Treatment Patterns for Osteoarthritis and Their Relationship to Patient-Reported Pain Severity: A Cross-Sectional Survey in the United States
by: Nalamachu SR, et al.
Published: (2020-12-01) -
Development and Validation of Direct-to-Physician Pharmaceutical Marketing Tool
by: Seyyed Mohammad Hossein Poorhashemi Ardakani, et al.
Published: (2019-03-01) -
Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
by: Ilinca D. Metes, et al.
Published: (2019-10-01)